Source: Getty Images Phase 2 data suggest that metastectomy in renal cell carcinoma may be associated with delayed disease progression and prolonged survival. At 24 weeks after surgery, metastasectomy ...
Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...